
Sispime 1000mg/125mg Injection
Marketer
Curosis Healthcare Pvt Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Sispime 1000mg/125mg Injection
The antibiotic injection, Sispime 1000mg/125mg, combines two antibacterial agents to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation. Administration must be strictly under medical guidance; adhere to all scheduled doses, completing the prescribed course regardless of symptom improvement. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. However, worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic responses such as skin rashes, itching, swelling, or breathing difficulties. Always inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs.
Uses of Sispime 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Sispime 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Sispime 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Sispime 1000mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Sispime 1000mg/125mg Injection works:
Cefepime/Tazobactam 1000mg/125mg injection unites a cephalosporin antibiotic (Cefepime) with a beta-lactamase inhibitor (Tazobactam). Cefepime's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counteracts bacterial enzymes (beta-lactamases) that would otherwise neutralize Cefepime. This combination broadens Cefepime's effectiveness by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Sispime 1000mg/125mg Injection and alcohol. Seek medical advice before doing so.
PregnancySAFE IF PRESCRIBED
The injectable medication Sispime (1000mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Sispime (1000mg/125mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Following administration of Sispime 1000mg/125mg Injection, temporary blurred vision may occur. Refrain from driving until your vision has returned to normal.
KidneyCAUTION
Patients with kidney impairment should use the 1000mg/125mg Sispime Injection cautiously. Dosage modification for this injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Sispime 1000mg/125mg Injection in individuals with hepatic impairment appears to present a low risk. Existing evidence indicates dose modification for Sispime 1000mg/125mg Injection might be unnecessary in such cases. However, physician consultation is recommended.
What if you forget to take Sispime 1000mg/125mg Injection :
Omitting a scheduled dose of Sispime 1000mg/125mg Injection necessitates contacting your physician.
Facts to Know About Sispime 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
